Familial Hypercholesterolemia;Hipercolesterolemia familiar

Revista de Investigacion Clinica

Volumn 53, Issue 3, 2001, Pages 254-265

  Aguilar Salinas, C A ^a  

^a NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; FAMILIAL DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MORTALITY; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED;

EID: 0034908136     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Diagnosing Heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics
2. Particle size and protein content of six fractions of the Sf > 20 plasma lipoproteins isolated by density gradient centrifugation
3. Simplified methods for measuring cholesterol concentrations of high density lipoprotein subclasses in serum compared
4. Isolation of DNA from biological specimens without extraction with phenol
5. Familial hypercholesterolemia
6. Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL receptor in a subject with clinical homozygous familial hypercholesterolemia
7. Effect of atorvastatin on serum-levels of lipoproteins in French Canadians with homozygous or compound heterozygous familial hypercholesterolemia
8. Treatment of familial hypercholesterolemia
9. Coronary disease in familial hypercholesterolemia
10. Molecular epidemiology of familial hypercholesterolaemia
11. The role of the LDL receptor in apolipoprotein B secretion
12. A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia
13. Increased production of HDL ApoAl in homozygous defective ApoB-100
14. Relationship between apolipoprotein (a) phenotype, lipoprotein (a) concentration in plasma and low density lipoprotein (LDL) receptor function in a large kindred with familial hypercholesterolemia due to the pro664-leu mutation in the LDL receptor gene
15. A world web site for low-density lipoprotein receptor gene mutations in familial hypercholesterolemia: Sequence-based tabular, and direct submission data handling
16. Familial defective apolipoprotein B-100
17. T3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia
18. Identification of the low density lipoprotein receptor binding site in apolipoprotein B 100 and the modulation of its binding activity by the carboxyl terminus in familial defective apoB100
19. Accumulation of small dense low density lipoproteins (LDL) in a homozygous patient with familial defective apolipoprotein B-100 results from heterogeneous interaction of LDL subfraction with the LDL receptor
20. Evidence for a third genetic locus causing familial hypercholesterolemia: A non LDLR, non-apo B Kindred
21. Mutations in the low density lipoprotein receptor gene in chinese familial hypercholesterolemia patients
22. Low density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia
23. A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1 - 1p32
24. Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia
25. 3500-Gln) allele specific polymerase chain reaction: Large-scale screening of pooled blood samples
26. Clinical criteria versus DNA diagnosis in heterozygous familial hypercholesterolemia
27. Mortality in treated heterozygous familial hypercholesterolemia: Implications for clinical management
28. Drug treatment of lipid disorders
29. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia
30. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: Implications for the pathophysiology of apoB production
31. Physiologic mechanisms of action of lovastatin in nephrotic syndrome
32. Description of a kindred with familial combined hyperlipidemia with unusual kinetic abnormalities of the apolipoprotein B containing lipoproteins. Effects of pravastatin therapy
33. Metabolic modes of action of statins in the hyperlipoproteinemias
34. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolemia
35. Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open- label study
36. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
37. Low density lipoprotein receptor genotype-dependent response to cholesterol lowering by combined pravastatin and cholestyramine in familial hypercholesterolemia
38. Clinical outcome of patients with familial hypercholesterolemia and coronary artery disease undergoing partial ileal bypass surgery
39. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
40. Cardiovascular gene therapy